NO20064629L - Rontgenkontrastmiddel-formulering omfattende en blanding av jodert monomer og dimer. - Google Patents

Rontgenkontrastmiddel-formulering omfattende en blanding av jodert monomer og dimer.

Info

Publication number
NO20064629L
NO20064629L NO20064629A NO20064629A NO20064629L NO 20064629 L NO20064629 L NO 20064629L NO 20064629 A NO20064629 A NO 20064629A NO 20064629 A NO20064629 A NO 20064629A NO 20064629 L NO20064629 L NO 20064629L
Authority
NO
Norway
Prior art keywords
mixture
dimer
ray contrast
contrast agent
agent formulation
Prior art date
Application number
NO20064629A
Other languages
English (en)
Norwegian (no)
Inventor
Muthunadar P Periasamy
Brian D Doty
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of NO20064629L publication Critical patent/NO20064629L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20064629A 2004-03-11 2006-10-10 Rontgenkontrastmiddel-formulering omfattende en blanding av jodert monomer og dimer. NO20064629L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55224004P 2004-03-11 2004-03-11
PCT/US2005/008389 WO2005087272A2 (en) 2004-03-11 2005-03-11 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer

Publications (1)

Publication Number Publication Date
NO20064629L true NO20064629L (no) 2006-11-28

Family

ID=34964357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064629A NO20064629L (no) 2004-03-11 2006-10-10 Rontgenkontrastmiddel-formulering omfattende en blanding av jodert monomer og dimer.

Country Status (12)

Country Link
US (1) US8679460B2 (enExample)
EP (2) EP1725268B1 (enExample)
JP (1) JP2007528424A (enExample)
KR (1) KR20070015517A (enExample)
CN (1) CN1938050A (enExample)
AT (1) ATE529135T1 (enExample)
AU (1) AU2005221716A1 (enExample)
CA (1) CA2559628A1 (enExample)
ES (1) ES2374633T3 (enExample)
IL (1) IL177888A0 (enExample)
NO (1) NO20064629L (enExample)
WO (1) WO2005087272A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445725B2 (en) * 2008-01-14 2013-05-21 Mallinckrodt Llc Process for the preparation of iosimenol
US11219696B2 (en) 2008-12-19 2022-01-11 Nationwide Children's Hospital Delivery of polynucleotides using recombinant AAV9
US20110256068A1 (en) * 2009-01-09 2011-10-20 Wistand Lars-Goeran Contrast media compositions
BR112012023063A2 (pt) * 2010-03-23 2016-05-17 Ge Healthcare As processo para a preparação de uma composição para raio x, e, composição de diagnóstico para raio x
US20130039888A1 (en) 2011-06-08 2013-02-14 Nationwide Children's Hospital Inc. Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders
JP2013091701A (ja) 2011-10-25 2013-05-16 Dow Corning Toray Co Ltd 硬化性組成物
US9725716B2 (en) * 2011-12-06 2017-08-08 Ohio State Innovation Foundation and Research Institute at Nationwide Children's Hospital Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
CA2862495A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
HK1206939A1 (en) * 2012-05-30 2016-01-22 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins
EP2879719B1 (en) 2012-08-01 2018-07-04 Nationwide Children's Hospital Intrathecal delivery of recombinant adeno-associated virus 9
KR102151088B1 (ko) * 2018-07-10 2020-09-02 한국원자력연구원 소체와 연결된 실 모양의 구조물 가시화 조성물 및 이의 가시화 방법
CN112386712B (zh) * 2020-11-09 2022-08-30 张洪 分子探针及其制备方法和用途
CN119656340A (zh) * 2024-12-13 2025-03-21 福安药业集团宁波天衡制药有限公司 一种碘佛醇注射液及其制备方法
CN120899953B (zh) * 2025-10-13 2025-12-12 浙江迪安鉴识科技有限公司 一种尸体用血管造影剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2511871A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants et produits opacifiants ainsi obtenus
US5698739A (en) 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
CA2124559A1 (en) * 1991-12-03 1993-06-10 Mills Thomas Kneller Nonionic x-ray contrast agents, compositions and methods
IT1256248B (it) 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
DE19627309C2 (de) * 1996-06-27 1999-07-29 Schering Ag Wäßrige injizierbare Formulierungen verwendbar als Kontrastmittel
US8518373B2 (en) * 2001-08-03 2013-08-27 Bracco Imaging Spa Ionic and non-ionic radiographic contrast agents for use in combined X-ray and nuclear magnetic resonance diagnostics
ITMI20011706A1 (it) 2001-08-03 2003-02-03 Bracco Imaging Spa Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance

Also Published As

Publication number Publication date
JP2007528424A (ja) 2007-10-11
AU2005221716A1 (en) 2005-09-22
CA2559628A1 (en) 2005-09-22
IL177888A0 (en) 2006-12-31
EP2253332A3 (en) 2011-03-23
US20080317675A1 (en) 2008-12-25
EP1725268B1 (en) 2011-10-19
EP1725268A2 (en) 2006-11-29
EP2253332A2 (en) 2010-11-24
US8679460B2 (en) 2014-03-25
ATE529135T1 (de) 2011-11-15
CN1938050A (zh) 2007-03-28
ES2374633T3 (es) 2012-02-20
KR20070015517A (ko) 2007-02-05
EP2253332B1 (en) 2012-10-10
WO2005087272A2 (en) 2005-09-22
WO2005087272A3 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
NO20064629L (no) Rontgenkontrastmiddel-formulering omfattende en blanding av jodert monomer og dimer.
TW200738666A (en) Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
GT200600164A (es) Derivados de dihidrobenzofuranos y usos de los mismos
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
DE69318727D1 (de) Wässerige einspritzbare Zusammensetzungen verwendbar zur Radiodiagnose enthaltenden jodierten aromatischen Verbindungen zur Verwendung als Röntgenkontrastmittel
ATE346058T1 (de) Glucocorticoid mimetika, verfahren zu ihrer herstellung, pharmazeutische formulierungen sie enthaltend und verwendungen davon
PL396711A1 (pl) Koniugaty polimerów z cytokinami, chemokinami, czynnikami wzrostu, hormonami polipeptydowymi i ich antagonistami, kompozycja farmaceutyczna i sposób zapobiegania, diagnozowania lub leczenia
MX2008000141A (es) Moduladores de lxr basados en imidazol.
MY143391A (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 (cyp3a4)
MX2007013065A (es) Derivados de dihidrobenzofurano y usos de los mismos.
CL2004000918A1 (es) Compuestos derivados de quinuclidina, antagonistas del receptor muscarinico m3; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para tratar una condicion anti-inflamatoria o alergica, en particular de las vias respiratoria
MY169274A (en) Fused, tricyclic sulfonamide inhibitors of gamma secretase
PA8556901A1 (es) Nuevos derivados de piperazina
TNSN08414A1 (en) Terphenyl derivatives for treatment of alzheimer's disease
ECSP077262A (es) Composicion antihistaminica
DE60230424D1 (en) Arylsulfonyl-derivate mit 5-ht 6-rezeptor-affinität
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
EP2098522A4 (en) NEW CONNECTION WITH AFFINITY TO AMYLOID
JP2017503808A5 (enExample)
ATE493410T1 (de) Neue verbindung mit affinität zu amyloid
ATE538124T1 (de) Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit
GB0425548D0 (en) Radiolabelled ligands
AR036533A1 (es) Compuestos agonistas de retinoides de alquil urea, su utilizacion, composiciones farmaceuticas que los comprenden y medicamentos basados en dichos compuestos
AR046768A1 (es) Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas
CL2004001431A1 (es) Compuestos derivados de 1-(alquilaminoalquil-/pirrolidin-/piperidinil)-2,2-difenilacetamida, antagonistas del receptor muscarinico; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica y uso del

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application